Biochemical properties of site-directed mutants of human epidermal growth factor: the importance of solvent-exposed hydrophobic residues of the amino-terminal domain in receptor binding

Abstract

Eight analogues of human epidermal growth factor (hEGF) having specific amino acid substitutions in the .beta.-sheet structure (residues 19-31) of the amino-terminal domain were generated by site-directed mutagenesis. Affinity of the epidermal growth factor (EGF) receptor for each of these mutant hEGF analogues was measured by both radioreceptor competition binding and receptor tyrosine kinase stimulation assays. The relative binding affinities obtained by these two methods were generally in agreement for each hEGF species. The results indicate that hydrophic residues on the exposed surface of the .beta.-sheet strucutre of the amino-terminal domain of hEGF have an important role in the formation of the active EGF-receptor complex. The substitution of hydrophobic amino acid residues, Val-19 .fwdarw. Gly, Met-21 .fwdarw. Thr, Ile-23 .fwdarw. Thr, and Leu 26 .fwdarw. Gly, resulted in decreased binding affinity, with the most severe reductions observed with the last two mutants. The mutations Ala-25 .fwdarw. Val and Lys-28 .fwdarw. Arg introduced amino acid residues resulting in slightly increased receptor binding affinity. Similar to previous results with acidic residues in this region [Engler, D. A., Matsunami, R. K., Campion, S. R., Stringer, C. D., Stevens, A. and Niyogi, S. K. (1988) J. Biol. Chem. 263, 12384-12390], removal of the positive charge in the Lys-28 .fwdarw. Leu substitution had almost no effect on binding affinity, indicating the lack of any absolute requirement for ionic interactions at this site. Substitution of Tyr-22, which resulted in decreased receptor binding affinity, provides further indication of the importance of aromatic residues in this region of the molecule, as found earlier with Tyr-29 (cf. reference above). These results provide direct evidence suggesting the importance of aliphatic and aromatic amino acid side chains, of the amino-terminal .beta.-sheet of the EGF molecule, in receptor-ligand interactions.